Ruprecht Zierz

Preclinical Efficacy of the Auristatin-Based Antibody–Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid Tumors

Anette Sommer, Charlotte Kopitz, Christoph A. Schatz et al. · Cancer Research · 2016 · 73 citations

Pathology, Tumor Biology, Preclinical Efficacy +16

The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1.

Hildegard P.M. Montz, Karl-M. Koch, Ruprecht Zierz et al. · PubMed · 1991 · 57 citations · Full text

Immunology, Immune Regulation, Cell Death +18

Elevated plasma levels of the immunosuppressive complement fragment Ba in renal failure

Martin Oppermann, Christian Kurts, Ruprecht Zierz et al. · Kidney International · 1991 · 48 citations

Glomerulonephritis, Complement System, Urology +12

IL3RA-Targeting Antibody–Drug Conjugate BAY-943 with a Kinesin Spindle Protein Inhibitor Payload Shows Efficacy in Preclinical Models of Hematologic Malignancies

Dennis Kirchhoff, Beatrix Stelte‐Ludwig, Hans‐Georg Lerchen et al. · Cancers · 2020 · 17 citations · Full text

A new animal model of venous thrombosis in rats with low flow conditions in the venous blood stream

Michaela Fredrich, Ruprecht Zierz, John Morser et al. · Blood Coagulation & Fibrinolysis · 1994 · 10 citations

Venous Blood Stream, Blood Flow, Thrombosis +21